MX2025007158A - Inhibidores de gmp?amp sintasa ciclica y sus usos - Google Patents
Inhibidores de gmp?amp sintasa ciclica y sus usosInfo
- Publication number
- MX2025007158A MX2025007158A MX2025007158A MX2025007158A MX2025007158A MX 2025007158 A MX2025007158 A MX 2025007158A MX 2025007158 A MX2025007158 A MX 2025007158A MX 2025007158 A MX2025007158 A MX 2025007158A MX 2025007158 A MX2025007158 A MX 2025007158A
- Authority
- MX
- Mexico
- Prior art keywords
- sup
- inhibitors
- cyclic gmp
- thiadiazole derivatives
- amp synthase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263433987P | 2022-12-20 | 2022-12-20 | |
| US202363501320P | 2023-05-10 | 2023-05-10 | |
| PCT/US2023/084787 WO2024137607A1 (en) | 2022-12-20 | 2023-12-19 | Thiadiazole derivatives as inhibitors of cyclic gmp-amp synthase and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2025007158A true MX2025007158A (es) | 2025-07-01 |
Family
ID=89768384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2025007158A MX2025007158A (es) | 2022-12-20 | 2025-06-18 | Inhibidores de gmp?amp sintasa ciclica y sus usos |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240270740A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4638446A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7870987B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250131845A (cg-RX-API-DMAC7.html) |
| CN (1) | CN120530109A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023408761A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2025001819A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2025007987A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL321525A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2025007158A (cg-RX-API-DMAC7.html) |
| PE (1) | PE20251918A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202434205A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024137607A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026077404A1 (zh) * | 2024-10-10 | 2026-04-16 | 北京知维拓医药科技有限公司 | 一种杂环类化合物及其用途 |
| WO2026158338A1 (zh) * | 2025-01-22 | 2026-07-30 | 北京知维拓医药科技有限公司 | 一种杂环类化合物及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| JP2016506408A (ja) | 2012-12-19 | 2016-03-03 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | 哺乳動物の環状ジヌクレオチドシグナル伝達経路の薬学的標的化 |
| DK3439667T3 (da) * | 2016-04-05 | 2024-04-02 | Immune Sensor Llc | Cgas antagonist forbindelser |
| US10738056B2 (en) * | 2017-09-15 | 2020-08-11 | Aduro Biotech Inc. | Pyrazolopyrimidinone compounds and uses thereof |
| MX2020008237A (es) | 2018-02-05 | 2020-09-25 | Univ Rockefeller | Inhibidores de 2,3,4,5-tetrahidro-1h-pirido[4,3-b]indol de cgas para tratar enfermedades autoinflamatorias. |
| WO2020072492A1 (en) * | 2018-10-02 | 2020-04-09 | Baruch S. Blumberg Institute | Benzamide derivatives as cgas-sting pathway agonists |
| JP7781074B2 (ja) * | 2020-05-20 | 2025-12-05 | エフ. ホフマン-ラ ロシュ アーゲー | Cgas阻害トリアゾロピリミドン誘導体 |
| WO2022137082A1 (en) * | 2020-12-22 | 2022-06-30 | Novartis Ag | Pyrrolo[3,2-b]pyridine derivatives useful in treating conditions associated with cgas |
| KR20230124665A (ko) * | 2020-12-22 | 2023-08-25 | 노파르티스 아게 | Cgas 관련 병태의 치료에 유용한 인돌 유도체 |
| EP4778593A2 (en) * | 2021-11-08 | 2026-07-22 | Ventus Therapeutics U.S., Inc. | Heterocyclic compounds and uses thereof |
| CN115160279B (zh) * | 2022-07-27 | 2023-11-24 | 中国药科大学 | 苯并吡喃酮类化合物、药物组合物和应用 |
-
2023
- 2023-12-19 EP EP23848029.7A patent/EP4638446A1/en active Pending
- 2023-12-19 KR KR1020257024220A patent/KR20250131845A/ko active Pending
- 2023-12-19 TW TW112149428A patent/TW202434205A/zh unknown
- 2023-12-19 PE PE2025001310A patent/PE20251918A1/es unknown
- 2023-12-19 AU AU2023408761A patent/AU2023408761A1/en active Pending
- 2023-12-19 WO PCT/US2023/084787 patent/WO2024137607A1/en not_active Ceased
- 2023-12-19 CN CN202380091713.0A patent/CN120530109A/zh active Pending
- 2023-12-19 US US18/544,945 patent/US20240270740A1/en active Pending
- 2023-12-19 IL IL321525A patent/IL321525A/en unknown
- 2023-12-19 JP JP2025536183A patent/JP7870987B2/ja active Active
-
2025
- 2025-06-13 CO CONC2025/0007987A patent/CO2025007987A2/es unknown
- 2025-06-18 MX MX2025007158A patent/MX2025007158A/es unknown
- 2025-06-18 CL CL2025001819A patent/CL2025001819A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7870987B2 (ja) | 2026-06-08 |
| AU2023408761A1 (en) | 2025-06-19 |
| IL321525A (en) | 2025-08-01 |
| PE20251918A1 (es) | 2025-08-05 |
| US20240270740A1 (en) | 2024-08-15 |
| CO2025007987A2 (es) | 2025-09-08 |
| TW202434205A (zh) | 2024-09-01 |
| EP4638446A1 (en) | 2025-10-29 |
| KR20250131845A (ko) | 2025-09-03 |
| CN120530109A (zh) | 2025-08-22 |
| WO2024137607A1 (en) | 2024-06-27 |
| CL2025001819A1 (es) | 2025-09-26 |
| JP2026501225A (ja) | 2026-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4299135A3 (en) | Benzisoxazole sulfonamide derivatives | |
| CR20230310A (es) | Inhibidores de prmt5 | |
| MX2025001619A (es) | Inhibidor de pde4b y uso del mismo | |
| MX2024007058A (es) | Derivados de 5,6,7,8-tetrahidro-2,6-naftiridina como terapeuticos contra el cancer. | |
| MX2023002547A (es) | Compuestos novedosos como inhibidor de histona desacetilasa 6 y composicion farmaceutica que comprende los mismos. | |
| PH12021552930A1 (en) | 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same | |
| CR20210602A (es) | Compuestos de pirrolidina | |
| MX2020007633A (es) | Péptidos macrocíclicos contra acinetobacter baumannii. | |
| NO20051265L (no) | Anvendelse av og noen nye imidazopyridiner | |
| PH12023550101A1 (en) | Novel compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same | |
| MX2022015886A (es) | Derivados de amidopirimidona. | |
| MX2023004033A (es) | Espiro derivados de alfa-d-galactopiranosidos. | |
| MX2023002686A (es) | Derivados de sulfamoil urea que contienen una porcion alquil-oxacicloalquilo y usos de los mismos. | |
| EP4599892A3 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| MX2022013890A (es) | Sintesis y derivados de acido boronico, formas polimorficas y usos terapeuticos de los mismos. | |
| MX2023003576A (es) | Compuesto como inhibidor de la akt cinasa. | |
| MX2025010952A (es) | Derivados de amida para inhibir el gen nlrp3 y usos de los mismos | |
| MY195576A (en) | Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof | |
| JOP20220281A1 (ar) | مركبات وتركيبات لتثبيط نشاط hif2 ألفا وطرق لاستخدامها | |
| MY133527A (en) | Isoquinoline derivatives | |
| WO2025014877A3 (en) | Triazolo wrn inhibitors | |
| MX2025010256A (es) | Derivados de hidroquinazolina para el tratamiento de una enfermedad o un trastorno | |
| WO2024254511A3 (en) | Wrn inhibitors | |
| CO2025007987A2 (es) | Derivados de tiadiazol como inhibidores de la sintasa de gmp-amp cíclico y usos de los mismos | |
| MX2024014315A (es) | Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas |